G C Harewood

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi Clinical implications of quantification of mesorectal tumor invasion by endoscopic ultrasound: All T3 rectal cancers are not equal
    Gavin C Harewood
    Department of Gastroenterology and Hepatology, Mayo Clinic, Minnesota, USA
    J Gastroenterol Hepatol 19:750-5. 2004
  2. ncbi Variation in practice of ileal intubation among diverse endoscopy settings: results from a national endoscopic database
    G C Harewood
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
    Aliment Pharmacol Ther 22:571-8. 2005
  3. ncbi What is the most sensitive screening method for the detection of colon cancer?
    Gavin C Harewood
    Mayo Clinic, Rochester, MN, USA
    Nat Clin Pract Gastroenterol Hepatol 2:134-5. 2005
  4. ncbi Pilot study to assess patient outcomes following endoscopic application of photodynamic therapy for advanced cholangiocarcinoma
    Gavin C Harewood
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA
    J Gastroenterol Hepatol 20:415-20. 2005
  5. ncbi Factors predicting success of endoscopic variceal ligation for secondary prophylaxis of esophageal variceal bleeding
    Gavin C Harewood
    Division of Gastroenterology and Hepatology, Mayo Clinic, Minnesota, USA
    J Gastroenterol Hepatol 21:237-41. 2006
  6. ncbi Incident rates of colonic neoplasia in older patients: when should we stop screening?
    Gavin C Harewood
    Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    J Gastroenterol Hepatol 21:1021-5. 2006
  7. ncbi Relationship of colonoscopy completion rates and endoscopist features
    Gavin C Harewood
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Dig Dis Sci 50:47-51. 2005
  8. ncbi Incident rates of colonic neoplasia according to age and gender: implications for surveillance colonoscopy intervals
    Gavin C Harewood
    Division of Gastroenterology and Hepatology, Gonda 9, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    J Clin Gastroenterol 39:894-9. 2005
  9. ncbi Colonoscopy practice patterns since introduction of medicare coverage for average-risk screening
    Gavin C Harewood
    Division of Gastroenterology and Hepatology, Charlton 8, Mayo Clinic, Rochester, Minnesota 55905, USA
    Clin Gastroenterol Hepatol 2:72-7. 2004
  10. ncbi Assessment of clinical impact of endoscopic ultrasound on esophageal cancer
    Gavin C Harewood
    Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Gastroenterol Hepatol 19:433-9. 2004

Detail Information

Publications74

  1. ncbi Clinical implications of quantification of mesorectal tumor invasion by endoscopic ultrasound: All T3 rectal cancers are not equal
    Gavin C Harewood
    Department of Gastroenterology and Hepatology, Mayo Clinic, Minnesota, USA
    J Gastroenterol Hepatol 19:750-5. 2004
    ..The purpose of the present paper was to determine if depth of invasion beyond MP, as assessed by preoperative endoscopic ultrasound (EUS), can predict tumor recurrence in patients with T3 rectal tumors...
  2. ncbi Variation in practice of ileal intubation among diverse endoscopy settings: results from a national endoscopic database
    G C Harewood
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
    Aliment Pharmacol Ther 22:571-8. 2005
    ..One of the major indications for terminal ileum intubation is to identify Crohn's disease. Signs and symptoms which raise a suspicion of Crohn's include abdominal pain/bloating, anaemia and diarrhoea...
  3. ncbi What is the most sensitive screening method for the detection of colon cancer?
    Gavin C Harewood
    Mayo Clinic, Rochester, MN, USA
    Nat Clin Pract Gastroenterol Hepatol 2:134-5. 2005
  4. ncbi Pilot study to assess patient outcomes following endoscopic application of photodynamic therapy for advanced cholangiocarcinoma
    Gavin C Harewood
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA
    J Gastroenterol Hepatol 20:415-20. 2005
    ..The aim of this pilot study was to assess the outcome in patients with non-resectable cholangiocarcinoma following endoscopic application of PDT directly into the biliary tract...
  5. ncbi Factors predicting success of endoscopic variceal ligation for secondary prophylaxis of esophageal variceal bleeding
    Gavin C Harewood
    Division of Gastroenterology and Hepatology, Mayo Clinic, Minnesota, USA
    J Gastroenterol Hepatol 21:237-41. 2006
    ....
  6. ncbi Incident rates of colonic neoplasia in older patients: when should we stop screening?
    Gavin C Harewood
    Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    J Gastroenterol Hepatol 21:1021-5. 2006
    ..However, there is no consensus regarding what age is appropriate to stop screening. The aim of this study was to characterize neoplasia occurrence/recurrence in a large cohort of patients > or =70 years of age undergoing colonoscopy...
  7. ncbi Relationship of colonoscopy completion rates and endoscopist features
    Gavin C Harewood
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Dig Dis Sci 50:47-51. 2005
    ..Future prospective studies should provide data to support consensus guidelines recommending minimum annual procedure numbers required for maintenance of endoscopic competence among trained endoscopists...
  8. ncbi Incident rates of colonic neoplasia according to age and gender: implications for surveillance colonoscopy intervals
    Gavin C Harewood
    Division of Gastroenterology and Hepatology, Gonda 9, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    J Clin Gastroenterol 39:894-9. 2005
    ..However, individual patients' risks may vary according to age and gender. This study aimed to characterize neoplasia recurrence in a large patient cohort undergoing surveillance colonoscopy...
  9. ncbi Colonoscopy practice patterns since introduction of medicare coverage for average-risk screening
    Gavin C Harewood
    Division of Gastroenterology and Hepatology, Charlton 8, Mayo Clinic, Rochester, Minnesota 55905, USA
    Clin Gastroenterol Hepatol 2:72-7. 2004
    ..Recent legislation passed in July 2001 provides coverage for all Medicare beneficiaries for average-risk screening colonoscopy...
  10. ncbi Assessment of clinical impact of endoscopic ultrasound on esophageal cancer
    Gavin C Harewood
    Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Gastroenterol Hepatol 19:433-9. 2004
    ..The aim of the present study was to assess the impact of EUS FNA by comparing the clinical outcomes of patients with esophageal cancer before and after the introduction of this staging modality in our institution...
  11. ncbi Economic comparison of current endoscopic practices: Barrett's surveillance vs. ulcerative colitis surveillance vs. biopsy for sprue vs. biopsy for microscopic colitis
    Gavin C Harewood
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Dig Dis Sci 49:1808-14. 2004
    ..Although, our findings put endoscopic practices into economic perspective, future perspective, future prospective trials are required to confirm the validity of these findings...
  12. ncbi Impact of endoscopist withdrawal speed on polyp yield: implications for optimal colonoscopy withdrawal time
    D T Simmons
    Division of Gastroenterology and Hepatology, Mayo College of Medicine, Rochester, MN, USA
    Aliment Pharmacol Ther 24:965-71. 2006
    ..Overall median polyp detection rate corresponded to a withdrawal time of 6.7 min. CONCLUSION: Our findings support a colonoscopy withdrawal time of at least 7 min, which correlates with higher colon polyp detection rates...
  13. ncbi Clinical implications of the extent of invasion of T3 esophageal cancer by endoscopic ultrasound
    Tony E Yusuf
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
    J Gastroenterol Hepatol 20:1880-5. 2005
    ..41, P = 0.14) or mortality (hazard ratio, 0.96; 95% CI: 0.49-1.78, P = 0.91). CONCLUSIONS: The extent of invasion of T3 esophageal cancer beyond MP, as determined by EUS, is not a significant predictor of tumor recurrence or mortality...
  14. ncbi Prospective assessment of the impact of feedback on colonoscopy performance
    G C Harewood
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
    Aliment Pharmacol Ther 24:313-8. 2006
    ..Colonoscopy is an operator-dependent procedure. The medical literature describes disparity in colonoscopy performance with respect to polyp detection, caecal intubation rates and procedural times...
  15. ncbi Prospective, randomized, controlled trial of prophylactic pancreatic stent placement for endoscopic snare excision of the duodenal ampulla
    Gavin C Harewood
    Division of Gastroenterology and Hepatology and Radiology, Developmental Endoscopy Unit, Mayo Clinic, Rochester, MN 55905, USA
    Gastrointest Endosc 62:367-70. 2005
    ..CONCLUSIONS: Our findings suggest that a protective effect is conferred by pancreatic stent placement in reducing postampullectomy pancreatitis. Future large-scale studies are required to confirm this benefit...
  16. ncbi A prospective, blinded assessment of the impact of preoperative staging on the management of rectal cancer
    Gavin C Harewood
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Gastroenterology 123:24-32. 2002
    ..EUS is more accurate than CT for determining T stage of rectal carcinoma...
  17. ncbi Cost-minimization analysis of alternative diagnostic approaches in a modeled patient with non-small cell lung cancer and subcarinal lymphadenopathy
    Gavin C Harewood
    Division of Gastroenterology and Hepatology and Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA
    Mayo Clin Proc 77:155-64. 2002
    ..Use of EUS FNA biopsy minimizes the cost of diagnostic evaluation in most cases...
  18. ncbi A cost analysis of endoscopic ultrasound in the evaluation of pancreatic head adenocarcinoma
    G C Harewood
    Developmental Endoscopy Unit, Mayo Clinic, Rochester, Minnesota 55905, USA
    Am J Gastroenterol 96:2651-6. 2001
    ..These results support performing EUS in patients whose tumors are thought to be resectable on helical CT to enhance NPT LN assessment...
  19. ncbi Cost-effectiveness analysis of alternative strategies for palliation of distal biliary obstruction after a failed cannulation attempt
    G C Harewood
    Division of Gastroenterology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Am J Gastroenterol 97:1701-7. 2002
    ..The endoscopic approach is best practiced by experienced endoscopists who minimize precut complication rates...
  20. ncbi Diagnostic approach to a patient with suspected celiac disease: a cost analysis
    G C Harewood
    Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Dig Dis Sci 46:2510-4. 2001
    ..In conclusion, initial screening with endomysial antibody is the least costly strategy for diagnosing celiac disease in a low risk population. Antigliadin antibody becomes the cheaper strategy for higher risk populations...
  21. ncbi A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures
    Todd H Baron
    Division of Gastroenterology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Clin Gastroenterol Hepatol 2:214-9. 2004
    ..Digital image analysis (DIA) allows quantification of nuclear DNA content and may help distinguish benign and malignant strictures of the biliary tract...
  22. ncbi EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma
    Ferga C Gleeson
    Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Gastrointest Endosc 67:438-43. 2008
    ..The clinical impact of EUS-guided FNA (EUS-FNA) in regional lymph-node staging in patients with unresectable hilar cholangiocarcinoma before liver transplantation has yet to be determined...
  23. ncbi Variation in small bowel biopsy performance among diverse endoscopy settings: results from a national endoscopic database
    Gavin C Harewood
    Division of Gastroenterology and Hepatology, Mayo Clinic Rochester, 200 First Street SW, Rochester, MN 55905, USA
    Am J Gastroenterol 99:1790-4. 2004
    ..The diagnosis of celiac sprue should be considered in such cases. Endoscopy provides an opportunity to obtain tissue to diagnose sprue, and should be strongly considered in this setting...
  24. ncbi Endoscopic ultrasound-guided trucut biopsy of the cyst wall for diagnosing cystic pancreatic tumors
    Michael J Levy
    Division of Gastroenterology and Hepatology, Mayo Clinic School of Medicine, Rochester, Minnesota 55905, USA
    Clin Gastroenterol Hepatol 3:974-9. 2005
    ..The aim of this study was to determine whether the tissue obtained by endoscopic ultrasound-guided trucut biopsy (EUS TCB) is sufficient for histologic diagnosis of cystic pancreatic tumors (CPTs)...
  25. ncbi Value of a negative colonoscopy in patients with non-specific gastrointestinal symptoms
    Tuba Esfandyari
    Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    J Gastroenterol Hepatol 22:1609-14. 2007
    ....
  26. ncbi A cost analysis of endoscopic ultrasound in the evaluation of esophageal cancer
    Gavin C Harewood
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Am J Gastroenterol 97:452-8. 2002
    ..Under certain circumstances, surgery is the preferred strategy...
  27. ncbi Endoscopic ultrasound for rectal cancer
    Maurits J Wiersema
    Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Gastroenterol Clin North Am 31:1093-105. 2002
    ..This will require further long-term outcome studies focusing on the endpoint of tumor recurrence and patient survival...
  28. ncbi Assessment of publication bias in the reporting of EUS performance in staging rectal cancer
    Gavin C Harewood
    Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Am J Gastroenterol 100:808-16. 2005
    ..CONCLUSION: The performance of EUS in staging rectal cancer may be overestimated in the literature due to publication bias. This inflated estimate of the capability of EUS may lead to unrealistic expectations of this technology...
  29. ncbi PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis
    E V Loftus
    Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA
    Gut 54:91-6. 2005
    ..Inflammatory bowel disease associated with primary sclerosing cholangitis (PSC-IBD) may have a high prevalence of rectal sparing, backwash ileitis, and colorectal neoplasia...
  30. ncbi Prospective, blinded assessment of factors influencing the accuracy of biliary cytology interpretation
    Gavin C Harewood
    Division of Gastroenterology and Hepatology, Department of Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Am J Gastroenterol 99:1464-9. 2004
    ..The knowledge of the patient's clinical information appears to clarify cytology interpretation resulting in fewer equivocal results. We did not detect any reliable predictors of cytology accuracy...
  31. ncbi Routine vs. selective EUS-guided FNA approach for preoperative nodal staging of esophageal carcinoma
    Enrique Vazquez-Sequeiros
    ivision of Gastroenterology and Hepatology, Pathology Department, Mayo Clinic Rochester, Rochester, Minnesota, USA
    Gastrointest Endosc 63:204-11. 2006
    ..A selective EUS-FNA approach reduced the cost by avoiding EUS-FNA in 42% of patients with esophageal carcinoma. These results require confirmation in future studies...
  32. ncbi Cost-effectiveness of endoscopic ultrasonography in the evaluation of proximal rectal cancer
    Gavin C Harewood
    Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Am J Gastroenterol 97:874-82. 2002
    ..Staging strategies incorporating EUS improve treatment allocation by achieving more accurate T staging, thereby optimizing the benefit of preoperative XRT to more advanced tumors...
  33. ncbi Influence of EUS training and pathology interpretation on accuracy of EUS-guided fine needle aspiration of pancreatic masses
    Gavin C Harewood
    Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Gastrointest Endosc 55:669-73. 2002
    ..EUS-FNA errors during the initial learning phase are primarily due to inadequate specimens. Interpretation of pancreatic EUS-FNA specimens remained consistent before and after training...
  34. ncbi Impact on patient outcomes of experience in the performance of endoscopic pancreatic fluid collection drainage
    Gavin C Harewood
    Division of Gastroenterology, Mayo Medical Center, Rochester, Minnesota, USA
    Gastrointest Endosc 58:230-5. 2003
    ..Future prospective studies assessing skill acquisition are required to define the minimum number of collection drainage procedures at which competence can be achieved...
  35. ncbi Endosonography-guided fine needle aspiration biopsy in the evaluation of pancreatic masses
    Gavin C Harewood
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Am J Gastroenterol 97:1386-91. 2002
    ..Complications were mild and infrequent (0.5%). CONCLUSION: EUS FNA of pancreatic masses safely and accurately diagnoses pancreatic malignancy when prior biopsy techniques have been unsuccessful...
  36. ncbi An assessment of the learning curve for precut biliary sphincterotomy
    G C Harewood
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Am J Gastroenterol 97:1708-12. 2002
    ..The need for precut sphincterotomy appears to decrease with increasing ERCP experience...
  37. ncbi A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy
    Gavin C Harewood
    Division of Gastroenterology and Hepatology, and Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
    Am J Gastroenterol 97:3186-94. 2002
    ..There does not seem to be any difference in the preferences expressed by never-screened and screened patients with respect to the aspects of colonoscopy that they find objectionable...
  38. ncbi EUS for rectal disease
    David A Schwartz
    Division of Gastroenterology and Hepatology, Vanderbilt University, Nashville, Tennessee, USA
    Gastrointest Endosc 56:100-9. 2002
  39. ncbi Assessment of the impact of an educational course on knowledge of appropriate EUS indications
    Gavin C Harewood
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
    Gastrointest Endosc 61:554-9. 2005
    ..Our findings suggest that education enhances gastroenterologists' understanding of EUS. Future studies should seek to assess the impact of these improved knowledge levels on the appropriateness of EUS referral patterns...
  40. ncbi Outcome differences after endoscopic drainage of pancreatic necrosis, acute pancreatic pseudocysts, and chronic pancreatic pseudocysts
    Todd H Baron
    Department of Medicine, Division of Gastroenterology, Mayo Medical Center, Rochester, Minnesota 55905, USA
    Gastrointest Endosc 56:7-17. 2002
    ..Outcomes differ depending on the type of pancreatic fluid collection drained. Further studies of endoscopic drainage of pancreatic fluid collections must use defined terminology to allow meaningful comparisons...
  41. ncbi Cost analysis of endoscopic antireflux procedures: endoluminal plication vs. radiofrequency coagulation vs. treatment with a proton pump inhibitor
    Gavin C Harewood
    Divisions of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA
    Gastrointest Endosc 58:493-9. 2003
    ..5 years. More long-term follow-up data are required to determine the durability of the endotherapy benefit over time...
  42. ncbi Colonic biopsy practice for evaluation of diarrhea in patients with normal endoscopic findings: results from a national endoscopic database
    Gavin C Harewood
    Division of Gastroenterology and Hepatology, Charlton 8, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Gastrointest Endosc 61:371-5. 2005
    ..Variation in biopsy practice exists among endoscopy site types and by gender. Clear guidelines are needed for the endoscopic approach to these patients...
  43. ncbi Assessment of clinical impact of endoscopic ultrasound on rectal cancer
    Gavin C Harewood
    Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Gastroenterol 99:623-7. 2004
    ..EUS use is associated with a recurrence-free survival advantage in patients, supporting its routine use in rectal cancer staging...
  44. ncbi Complications of temporary pancreatic stent insertion for pancreaticojejunal anastomosis during pancreaticoduodenectomy
    Michael J Levy
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Gastrointest Endosc 59:719-24. 2004
    ..The patient with pancreatitis has not experienced another episode. CONCLUSIONS: The possibility of a retained stent should be considered in patients presenting with steatorrhea or pancreatitis after pancreaticoduodenectomy...
  45. ncbi Cost analysis of magnetic resonance cholangiography in the management of inoperable hilar biliary obstruction
    G C Harewood
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Am J Gastroenterol 97:1152-8. 2002
    ..The uncertainty of any survival advantage that bilateral biliary stent placement confers over unilateral stent placement makes cost-effectiveness difficult to assess...
  46. ncbi Prospective comparison of endoscopy patient satisfaction surveys: e-mail versus standard mail versus telephone
    G C Harewood
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Am J Gastroenterol 96:3312-7. 2001
    ..The satisfaction levels of the responders may underestimate the overall satisfaction of the population being surveyed...
  47. ncbi International survey of knowledge of indications for EUS
    Tony E Yusuf
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Gastrointest Endosc 63:107-11. 2006
    ..Future educational initiatives should focus on applications of EUS in this category. Studies are required to assess the impact of this education on the appropriateness of EUS referral patterns...
  48. ncbi Initial experience with EUS-guided trucut needle biopsies of perigastric organs
    Maurits J Wiersema
    Developmental Endoscopy Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Gastrointest Endosc 56:275-8. 2002
    ..Further study of the utility and safety of this needle in humans is warranted...
  49. ncbi Utility of endoscopic ultrasound in the diagnosis of aberrant right subclavian artery
    Tony E Yusuf
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Gastroenterol Hepatol 22:1717-21. 2007
    ..The aim of this study was to determine the prevalence of ARSA in patients undergoing upper endoscopic ultrasound (EUS) and to describe the EUS characteristics of ARSA...
  50. ncbi Detection of occult upper gastrointestinal tract bleeding: performance differences in fecal occult blood tests
    Gavin C Harewood
    Division of Gastroenterology and Hepatology and Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA
    Mayo Clin Proc 77:23-8. 2002
    ..003). CONCLUSION: The HQT test detects occult upper GI tract blood loss significantly more frequently than the HO or HS test...
  51. ncbi Abdominal CT as a predictor of outcome before attempted direct percutaneous endoscopic jejunostomy
    John T Maple
    Department of Internal Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Gastrointest Endosc 63:424-30. 2006
    ..Otherwise, review of existing abdominal CTs appears to have limited utility in predicting DPEJ outcome...
  52. ncbi Knowledge of indications for EUS among gastroenterologists and non-gastroenterologists
    Tony E Yusuf
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Gastrointest Endosc 60:575-9. 2004
    ..Future studies should focus on the education of non-gastroenterologists regarding the role of EUS and assess the impact of such education on the appropriateness of EUS referral patterns...
  53. ncbi Assessment of patients' perceptions of bowel preparation quality at colonoscopy
    Gavin C Harewood
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Am J Gastroenterol 99:839-43. 2004
    ..Conversely, a patient's fear that their preparation is suboptimal is also inaccurate. A colonoscopy should not be canceled on the basis of a patient's perception that the quality of their preparation is poor...
  54. ncbi Prevalence of advanced neoplasia at screening colonoscopy in men in private practice versus academic and Veterans Affairs medical centers
    Gavin C Harewood
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Am J Gastroenterol 98:2312-6. 2003
    ..One must be cautious in generalizing the findings of male patient studies from academic centers to the entire population...
  55. ncbi Prospective controlled assessment of variable stiffness enteroscopy
    Gavin C Harewood
    Division of Gastroenterology and Hepatology and Radiology, Developmental Endoscopy Unit, Mayo Clinic, Rochester, Minnesota, USA
    Gastrointest Endosc 58:267-71. 2003
    ..Further studies are required to determine whether this improved performance increases diagnostic yield...
  56. ncbi Impact of colonoscopy preparation quality on detection of suspected colonic neoplasia
    Gavin C Harewood
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Gastrointest Endosc 58:76-9. 2003
    ..These results suggest that inadequate preparation quality only hinders detection of smaller lesions, while having negligible impact on detection of larger lesions. These results should be confirmed in prospective studies...
  57. ncbi Biopsy specimen acquisition in patients with newly diagnosed peptic ulcer disease as determined from a national endoscopic database
    Gavin C Harewood
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Gastrointest Endosc 59:664-9. 2004
    ..Given the established benefit of Helicobacter pylori eradication, further study is needed to determine whether physicians are diagnosing and treating Helicobacter pylori infection adequately in patients with peptic ulcer...
  58. ncbi EUS-guided trucut biopsy in establishing autoimmune pancreatitis as the cause of obstructive jaundice
    Michael J Levy
    Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Gastrointest Endosc 61:467-72. 2005
    ..Doing so helps guide management and may help to avoid unnecessary surgery. Prospective studies are needed to verify these findings and to more clearly define the role of EUS TCB in these patients...
  59. ncbi Endoscopic factors in the diagnosis of colorectal dysplasia in chronic inflammatory bowel disease
    Murat Toruner
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Inflamm Bowel Dis 11:428-34. 2005
    ..CONCLUSIONS: Our results show that the practice of surveillance colonoscopy varies greatly among endoscopists, and longer procedure duration is significantly associated with the likelihood of dysplasia diagnosis...
  60. ncbi Evaluation of polyp detection in relation to procedure time of screening or surveillance colonoscopy
    William Sanchez
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Gastroenterol 99:1941-5. 2004
    ..These results should prompt future prospective studies assessing the impact of colonoscopic withdrawal time on lesion detection...
  61. ncbi Enteral self-expandable stents
    Todd H Baron
    Department of Medicine, Division of Gastroenterology and Hepatology, Mayo Foundation, Rochester, Minnesota, USA
    Gastrointest Endosc 58:421-33. 2003
  62. ncbi Assessment of predictors of response to neostigmine for acute colonic pseudo-obstruction
    Conor G Loftus
    Division of Gastroenterology and Hepatology, Mayo Medical Center, Rochester, Minnesota, USA
    Am J Gastroenterol 97:3118-22. 2002
    ..Neostigmine appears to be under-used in patients with ACPO who do not have a true contraindication to its use...
  63. ncbi Assessment of the predictors of response to glucagon in the setting of acute esophageal food bolus impaction
    Thomas C Sodeman
    Department of Medicine, Division of Gastroenterology, Mayo Medical Center, Rochester, Minnesota, USA
    Dysphagia 19:18-21. 2004
    ..An impacted meat bolus is more likely to require intervention for removal than other food types. These clinical predictors should be considered before administration of glucagon...
  64. ncbi Comparison of direct percutaneous endoscopic jejunostomy and PEG with jejunal extension
    Andy C Fan
    Division of Gastroenterology and Hepatology, Mayo Medical Center, Rochester, Minnesota, USA
    Gastrointest Endosc 56:890-4. 2002
    ....
  65. ncbi Endoscopic balloon dilation of the biliary sphincter compared to endoscopic biliary sphincterotomy for removal of common bile duct stones during ERCP: a metaanalysis of randomized, controlled trials
    Todd H Baron
    Department of Medicine, Division of Gastroenterology and Hepatology, Mayo Medical Center, Rochester, Minnesota, USA
    Am J Gastroenterol 99:1455-60. 2004
    ..Although EPBD is theoretically attractive for use in young patients for biliary sphincter preservation, the rate of pancreatitis is higher with EPBD and cannot be routinely recommended at this time...
  66. ncbi Utility of endoscopic ultrasound for restaging rectal cancer following neoadjuvant chemoradiation therapy
    Gavin C Harewood
    Am J Gastroenterol 99:953; author reply 954. 2004
  67. ncbi Prophylactic clip application after colonic polypectomy
    Gavin C Harewood
    Gastrointest Endosc 65:183; author reply 183. 2007
  68. ncbi Treatment of rectal cancer
    Gavin C Harewood
    N Engl J Med 355:2486; author reply 2487-8. 2006
  69. ncbi Treatment of gastric cancer
    Gavin C Harewood
    N Engl J Med 355:1386; author reply 1387-8. 2006
  70. ncbi Radiotherapy for rectal cancer
    Gavin C Harewood
    N Engl J Med 346:137-8. 2002
  71. ncbi Recommendations for endoscopy in the patient on chronic anticoagulation: apply with care!
    Gavin C Harewood
    Gastrointest Endosc 64:79-81. 2006
  72. ncbi Colonoscopy: Not quite the gold standard
    Gavin C Harewood
    Department of Gastroenterology, Beaumont Hospital, Dublin, Ireland
    Dig Liver Dis 39:690-1. 2007
  73. ncbi Measuring colonoscopy performance among gastroenterology trainees
    Gavin C Harewood
    Gastrointest Endosc 68:407. 2008